Notable Labs, Ltd.
NASDAQ: NTBL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kaile Zagger
- Employees
- 16
- Headquarters
- Or-Yehuda, Israel
- IPO year
- 2014
- Market cap
- $2.4M
- Website
- https://www.notablelabs.com
Loading NTBL…
Loading profile data…Frequently asked questions about NTBL
What does Notable Labs, Ltd. (NTBL) do?
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely resp...
Where does NTBL trade?
Notable Labs, Ltd. (NTBL) trades on the NASDAQ Capital Market.
What sector is NTBL in?
Notable Labs, Ltd. (NTBL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Notable Labs, Ltd.?
Kaile Zagger is the chief executive officer of Notable Labs, Ltd. (NTBL).
Where is Notable Labs, Ltd. headquartered?
Notable Labs, Ltd. is headquartered in Israel.
Does NTBL pay a dividend?
Notable Labs, Ltd. (NTBL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NTBL go public?
Notable Labs, Ltd. (NTBL) completed its initial public offering in 2014.